𝔖 Bobbio Scriptorium

✦ LIBER ✦

Oligomers of prostaglandin B1 (PGBx), are antioxidants and phospholipase A2 (PLA2) inhibitors with cytoprotective activity

✍ Scribed by R. Franson; W. Regelson; M.D. Rosenthal

Book ID: 113385297
Publisher: Elsevier Science
Year: 1990
Tongue: English
Weight: 110 KB
Volume: 9
Category: Article
ISSN: 0891-5849
DOI: 10.1016/0891-5849(90)90679-d

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Mechanism(s) of cytoprotective and anti-

Mechanism(s) of cytoprotective and anti-inflammatory activity of PGB1 oligomers: PGBx has potent anti-phospholipase A2 and anti-oxidant activity

✍ Franson, R.C.; Rosenthal, M.D.; Regelson, W. 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 964 KB

Simultaneous presence of platelet activa

Simultaneous presence of platelet activating factor, leukotriene B4, prostaglandin F1α and F2α in the supernatant of human neutrophils treated with phospholipase A2 of human monocytes

✍ Sipka, S. ;Dinya, Z. ;Gergely, P. ;Farkas, T. ;Szegedi, G. 📂 Article 📅 1989 🏛 Springer-Verlag 🌐 English ⚖ 257 KB

Regulation of synovial cell growth: basi

Regulation of synovial cell growth: basic fibroblast growth factor synergizes with interleukin 1β stimulating phospholipase A2 enzyme activity, phospholipase A2 activating protein production and release of prostaglandin E2 by rheumatoid arthritis synovial cells in culture

✍ Goddard, David H.; Grossman, Scott L.; Newton, Robert; Clark, Mike A.; Bomalaski 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 1020 KB

Posttreatment with EPC-K1, an inhibitor

Posttreatment with EPC-K1, an inhibitor of lipid peroxidation and of phospholipase A2 activity, reduces functional deficits after global ischemia in rats

✍ Block, F.; Kunkel, M.; Sontag, K.-H. 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 433 KB

Ribonucleotide reductase inhibitors, did

Ribonucleotide reductase inhibitors, didox and trimidox, demonstrate antiretroviral activity alone or in combination with DDI in a murine acquired immunodeficiency (MAIDS) model: H. Elford1, B. Van't Riet1, C. Mayhew2, O. Oakley2, N. Hughes2, J. Piper2, V. Gallicchio2. 1Molecules for Health, Inc., Richmond, VA; 2University of Kentucky, Lexington, KY

📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 104 KB

HIV-1 specific phenylacetamide derivativ

HIV-1 specific phenylacetamide derivatives: A novel class of reverse transcriptase inhibitors with potent and selective antiviral activity in vitro : R. Pauwels1, K. Andries2, Z. Debyser1, P. Van Daele2, D. Schols1, M.A.C. Janssen2, J. Desmyter1, E. De Clercq1 and P.A.J. Janssen2 1Rega Institute for Medical Research, Katholieke Universiteit Leuven, B-3000 Leuven, Belgium and 2Janssen Research Foundation, B-2340 Beerse, Belgium

📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 72 KB